Abstract
There are many vascular anomalies which are often a diagnostic and therapeutic challenge. They are classified in vascular tumors (e.g. infantile hemangioma) or vascular malformations (e.g. port-wine-stain). Moreover there are several other and rare vascular disregulations and diseases in the field of dermatology. Many laser systems focus on the therapy of vascular pathologies. We use a pulsed dye laser (595 nm) on its own or in combination with a Neodym:YAG-laser (1064 nm) to treat those vascular diseases. This paper points out the advantages and side effects of these two laser systems and describes the limitations of those.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. Wassef, F. Blei, D. Adams, A. Alomari, E. Baselga, A. Berenstein, P. Burrows, I. J. Frieden, M. C. Garzon, J. C. Lopez-Gutierrez, D. J. E. Lord, S. Mitchel, J. Powell, J. Prendiville and M. Vikkula, Vascular anomalies classification: Recommendations from the international society for the study of vascular anomalies, Pediatrics, 2015, 136, 203–214.
K. M. Kaune, P. Lauerer, S. Kietz, K. M. Thoms, M. P. Schön and M. Zutt, Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe, J. Dtsch. Dermatol. Ges., 2014, 12(6), 473–478.
J. Alcántara-González, P. Boixeda, M. T. Truchuelo-Diez, B. Pérez-Garcia, L. Alonso-Castro and P. Jaén Olasolo, Infantile hemangiomas treated by sequential application of pulsed dye laser and Nd:YAG laser radiation: a retrospective study, Actas Dermosifiliogr., 2013, 104(6), 504–511.
L. L. Randeberg, J. H. BonesrØnning, M. Dalaker, J. S. Nelson and L. O. Svaasand, Methemoglobin formation during laser induced photothermolysis of vascular skin lesions, Lasers Surg. Med., 2004, 34(5), 414–419.
C. Léauté-Labrèze, S. Prey and K. Ezzedine, Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities, J. Eur. Acad. Dermatol. Venereol., 2011, 25(11), 1245–1253.
M. Landthaler, U. Hohenleutner and T. A. El-Raheem, Laser therapy of childhood haemangiomas, Br. J. Dermatol., 1995, 133(2), 275–281.
A. M. Saafan and M. M. Salah, Using pulsed dual-wave-length 595 and 1064 nm is more effective in the management of hemangiomas,J. Drugs Dermatol., 2010, 9(4), 310–314.
K. K. Reddy, J. A. Brauer, M. H. Idriss, R. Anolik, L. Bernstein, L. Brightman, E. Hale, J. Karen, E. Weiss, D. Elston and R. G. Geronemus, Treatment of port-wine stains with a short pulse width 532 nm Nd:YAG laser, J. Drugs Dermatol., 2013, 12(1), 66–71.
W. Jia, V. Sun, N. Tran, B. Choi, S. W. Liu, M. C. Mihm Jr., T. L. Phung and J. S. Nelson, Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment, Lasers Surg. Med., 2010, 42(2), 105–112.
L. Vlachakis, S. Gardikis, E. Michailoudi and G. Charissis, Treatment of hemangiomas in children using a Nd:YAG laser in conjunction with ice cooling oft he epidermis: techniques and results, BMC Pediatr., 2003, 12(3), 2.
A. N. Haggstrom, B. A. Drolet, E. Baselga, S. L. Chamlin, M. C. Garzon, K. A. Horii, A. W. Lucky, A. J. Mancini, D. W. Metry, B. Newell, A. J. Nopper and I. J. Frieden, Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment, Pediatrics, 2006, 118(3), 882–887.
S. M. Maguiness and I. J. Frieden, Management of difficult infantile haemangiomas, Arch. Dis. Child., 2012, 97(3), 266–271.
C. Léauté-Labrèze, E. Dumas de la Roque, T. Hubiche, F. Boralevi, J. B. Thambo and A. Taïeb, Propranolol for severe hemangiomas of infancy, N. Engl. J. Med., 2008, 358(24), 2649–2651.
W. Mousa, K. Kues, E. Haas, P. Lauerer, H. Pavlakovic, M. P. Schön and M. Zutt, Successful treatment of a large hemangioma with propranolol, J. Dtsch. Dermatol. Ges., 2010, 8(3), 184–186.
M. de Graaf, J. M. P. J. Breur, M. F. Raphaël, M. Vos, C. C. Breugem and S. G. M. A. Pasmans, Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants, J. Am. Acad. Dermatol., 2011, 65(2), 320–327.
H. Pavlakovic, S. Kietz, P. Lauerer, M. Zutt and M. Lakomek, Hyperkalemia complicating propranolol treatment of an infantile hemangioma, Pediatrics, 2010, 126(6), 1589–1593.
J. W. Zheng, L. Zhang, Q. Zhou, H. M. Mai, Y. A. Wang, X. D. Fan, Z. P. Qin, X. K. Wang and Y. F. Zhao, A practical guide to treatment of infantile hemangiomas of the head and neck, Int. J. Clin. Exp. Med., 2013, 6(10), 851–860.
H. Zaher, H. Rasheed, R. A. Hegazy, D. M. Abdelhalim and H. J. Gawdat, Oral propranolol: an effective, safe treatment for infantile hemangiomas, Eur. J. Dermatol., 2011, 21(4), 558–563.
F. Hartmann, A. Lockmann, L. L. Grönemeyer, H. A. Haenssle, M. Zutt, H. von Fintel, I. Kühnle, M. P. Schön and K. M. Thoms, Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children, J. Eur. Acad. Dermatol. Venereol., 2017, 31, 1372–1379.
K. M. Cordoro, L. S. Speetzen, M. A. Koerper and I. J. Frieden, Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications, J. Am. Acad. Dermatol., 2009, 60(4), 669–675.
R. G. Geronemus and R. Ashinoff, The medical necessity of evaluation and treatment of port-wine stains, J. Dermatol. Surg. Oncol., 1991, 17(1), 76–79.
R. Ashinoff and R. G. Geronemus, Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment, J. Am. Acad. Dermatol., 1991, 24(3), 467–472.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zutt, M. Laser treatment of vascular dermatological diseases using a pulsed dye laser (595 nm) in combination with a Neodym:YAG-laser (1064 nm). Photochem Photobiol Sci 18, 1660–1668 (2019). https://doi.org/10.1039/c9pp00079h
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c9pp00079h